Rapid changes resulting from personalized medicine, including the ability to use individual patient biomarker data to generate a tailored treatment, are transforming healthcare.  New business structures are evolving in the healthcare marketplace to meet the need for integrating diagnostic data to deliver individualized patient treatment. Diagnostic and therapeutic businesses are forming increasingly complex contractual arrangements … Continue reading this entry